8 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp02594 | Cyclic [W(RW)4 ]-Dox | WRWRWRWRW | Not found | Inhibition of the cell proliferation | MTT/MTS assay | CCRF-CEM | Leukemia cancer | 62-73% inhibition of cell proliferation at 1 µM |
| dbacp02595 | Cyclic [W(RW)4 ]-Dox | WRWRWRWRW | Not found | Inhibition of the cell proliferation | MTT/MTS assay | SK-OV-3 | Ovarian cancer | 51-74% inhibition of cell proliferation at 1 µM |
| dbacp02596 | Cyclic [W(RW)4 ]-Dox | WRWRWRWRW | Not found | Inhibition of the cell proliferation | MTT/MTS assay | HCT-116 | Colon cancer | 50-67% inhibition of cell proliferation at 1 µM |
| dbacp02597 | Cyclic [W(RW)4 ]-Dox | WRWRWRWRW | Not found | Inhibition of the cell proliferation | MTT/MTS assay | MDA-MB-468 | Breast cancer | 60-79% inhibition of cell proliferation at 1 µM |
| dbacp04103 | linear (RW)4-Dox | RWRWRWRW | Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP | Inhibition of the cell proliferation | MTT/MTS assay | CCRF-CEM | Leukemia cancer | 46-69% anti-proliferative activity at 1 µM |
| dbacp04104 | linear (RW)4-Dox | RWRWRWRW | Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP | Inhibition of the cell proliferation | MTT/MTS assay | SK-OV-3 | Ovarian cancer | 28-34% anti-proliferative activity at 1 µM |
| dbacp04105 | linear (RW)4-Dox | RWRWRWRW | Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP | Inhibition of the cell proliferation | MTT/MTS assay | HCT-116 | Colon cancer | 21-61% anti-proliferative activity at 1 µM |
| dbacp04106 | linear (RW)4-Dox | RWRWRWRW | Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP | Inhibition of the cell proliferation | MTT/MTS assay | MDA-MB-468 | Breast cancer | 60-74% anti-proliferative activity at 1 µM |